Cambridge University Health Partners

GigXR HoloScenarios Named to TIME’s List of the Best Inventions of 2022; Recognizes Holographic Patient Simulation as Life-Changing Innovation

Retrieved on:

Thursday, November 10, 2022

Technology, Training, Communications, Health Technology, Defense, Artificial Intelligence, Government Technology, Research, Media, Hospitals, University, Education, Health, Practice Management, Apps, Applications, General Health, Audio, Video, Science, Other Technology, Telecommunications, Telemedicine, Virtual Medicine, Software, Publishing, Cambridge Biomedical Campus, AstraZeneca, Hospital, Carbon, Gig, Cambridge University Hospitals NHS Foundation Trust, Anesthesiology, 3D, TIME, Extended reality, Partnership, Communication, Education, Health, Catalog, Department, NIHR, CBC, Technology, Smartphone, Invention, Internet access, Department of Defense Serum Repository, XR, Royal Papworth Hospital, CUH, Cambridge University Health Partners, University, Trauma, Atmosphere, Solution, CA, Rosie Hospital, Asthma, Consultant, NHS, Anaphylaxis, Pulmonary embolism, Michigan Medicine, Patient, Judgement, Heart, CEO, Medicine, Medical device, Neuroscience, Campus

GigXR, Inc. , a global provider of holographic healthcare training, announced today that its mixed reality patient training application, HoloScenarios, has been awarded TIMES 2022 Best Inventions .

Key Points:

GigXR, Inc. , a global provider of holographic healthcare training, announced today that its mixed reality patient training application, HoloScenarios, has been awarded TIMES 2022 Best Inventions .
To ensure medical integrity and realism of HoloScenarios, GigXR partners with healthcare subject matter experts to inform and guide the creation of the holographic simulations.
We couldnt be more honored to share TIMES 2022 Best Inventions Award with the team and technologists at GigXR.
To see the full list of TIMEs List of the Best Inventions of 2022, visit time.com/best-inventions-2022 .

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Retrieved on:

Tuesday, January 25, 2022

As one of the leading UK biomedical research organisations, the NIHR Cambridge BRC maintains a secure source of fully consented clinico-genomic data from patients with chronic diseases and cancer.

Key Points:

As one of the leading UK biomedical research organisations, the NIHR Cambridge BRC maintains a secure source of fully consented clinico-genomic data from patients with chronic diseases and cancer.
The mission of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research.
Based within the most outstanding NHS and University partnerships in the country, the Biomedical Research Centres are leaders in scientific translation.
Located on the Cambridge Biomedical Campus, they receive substantial levels of funding from the National Institute for Health Research (NIHR) to translate fundamental biomedical research into clinical research that benefits patients and they are early adopters of new treatments.

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Retrieved on:

Tuesday, January 25, 2022

As one of the leading UK biomedical research organisations, the NIHR Cambridge BRC maintains a secure source of fully consented clinico-genomic data from patients with chronic diseases and cancer.

Key Points:

As one of the leading UK biomedical research organisations, the NIHR Cambridge BRC maintains a secure source of fully consented clinico-genomic data from patients with chronic diseases and cancer.
The mission of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research.
Based within the most outstanding NHS and University partnerships in the country, the Biomedical Research Centres are leaders in scientific translation.
Located on the Cambridge Biomedical Campus, they receive substantial levels of funding from the National Institute for Health Research (NIHR) to translate fundamental biomedical research into clinical research that benefits patients and they are early adopters of new treatments.

Cancer Patients May Get Faster and More Personalized Treatment as Result of Collaboration Between GE Healthcare, University of Cambridge and Addenbrooke’s Hospital

Retrieved on:

Monday, November 29, 2021

Technology, Medical Devices, Surgery, Hospitals, Other Technology, Managed Care, Health, Science, Oncology, Other Science, Newton, Patient, Ovarian cancer, News, University, Heart, CUH, Health information management, Cambridge Biomedical Campus, GE Healthcare, Technology, Disease, Surgeon, NYSE, Social, Cambridge Institute for Sustainability Leadership, Diagnosis, Rosie Hospital, Cancer, Cambridge Centre, Department of Oncology, University of Cambridge, University of Cambridge, Breast, Cancer Research UK, Student, NIHR, Education, AstraZeneca, Department, MDT, CBC, Thomas Edison, Information system, Humanities, Twitter, College, Cambridge University Hospitals NHS Foundation Trust, Research, Radiology, Health, Cambridge University Health Partners, Patent, Royal Papworth Hospital, EHR, Science, Learning, Cancer research, Medicine, Engineering, Ecosystem, LinkedIn, RIS, Marie Cassidy, Medical imaging, Pharmaceutical industry, Industrial design, Sales, GE Healthcare, The University of Cambridge, Cambridge University Hospitals, GE HEALTHCARE, THE UNIVERSITY OF CAMBRIDGE, CAMBRIDGE UNIVERSITY HOSPITALS

Thanks to ever-improving technologies, we now generate increasing amounts of complex data for each patient with cancer.

Key Points:

Thanks to ever-improving technologies, we now generate increasing amounts of complex data for each patient with cancer.
The application is expected to be evaluated for ovarian cancer initially in Cambridge and the goal is to evaluate it across the UK, and beyond.
If the application is successfully developed, our vision is for it to be expanded for use in breast and kidney cancer patients.
CUH is a leading national centre for specialist treatment for rare or complex conditions and a university teaching hospital with a worldwide reputation.